Retraction: Surface modification engineering of two-dimensional titanium carbide for efficient synergistic multitherapy of breast cancer.
1/5 보강
Retraction of 'Surface modification engineering of two-dimensional titanium carbide for efficient synergistic multitherapy of breast cancer' by Lei Bai , , 2020, , 6402-6417, https://doi.org/10.1039/D
APA
Bai L, Yi W, et al. (2026). Retraction: Surface modification engineering of two-dimensional titanium carbide for efficient synergistic multitherapy of breast cancer.. Journal of materials chemistry. B, 14(8), 2663. https://doi.org/10.1039/d6tb90024k
MLA
Bai L, et al.. "Retraction: Surface modification engineering of two-dimensional titanium carbide for efficient synergistic multitherapy of breast cancer.." Journal of materials chemistry. B, vol. 14, no. 8, 2026, pp. 2663.
PMID
41670383 ↗
Abstract 한글 요약
Retraction of 'Surface modification engineering of two-dimensional titanium carbide for efficient synergistic multitherapy of breast cancer' by Lei Bai , , 2020, , 6402-6417, https://doi.org/10.1039/D0TB01084G.
같은 제1저자의 인용 많은 논문 (5)
- Nicotinamide prevents anti-PD1 immune checkpoint inhibitor-associated early stages of cardiotoxicity.
- YEATS2/TAK1 axis mediates TGF-β1 driven adaptive resistance to sorafenib in hepatocellular carcinoma.
- FBXO22 promotes hepatocellular carcinoma progression via paracrine myo‑inositol‑induced M2‑type polarization of macrophages.
- The Dual Role of DNA Hypermethylation and Hypomethylation in Colorectal and Gastric Tumorigenesis: Mechanisms and Non-Invasive Biomarker.
- A tumor immune microenvironment gene expression signature for predicting prognosis, immunotherapy efficacy, and drug candidates in triple-negative breast cancer.